52
This audio is auto-generated. Please let us know if you have feedback.
The search for the next wave of GLP-1s is pushing Big Pharma east, and China is quickly becoming the top destination to shop for promising pipeline assets.
China’s biotech sector has become a major hub of drug innovation, driven in large part by government initiatives to rapidly advance the nation’s pharma R&D…